Halaman 3 - Kanker rahim Dokter Terbaik - TOP-102 dokter

Dr. Topcu spesialis dalam pengobatan kanker rahim dengan pelatihan internasional yang luas di pusat kanker terkemuka seperti MD Anderson dan Moffit.

• Spesialis onkologi medis dengan pengalaman 15+ tahun
• Terlatih di MD Anderson Cancer Center dan Sunnybrook Odette Cancer Center
• Ahli dalam kanker ginekologi termasuk rahim dan ovarium
• Bekerja di Valued Med Hub Hospitals

Spesialis kanker urogenital dengan fokus pada pengobatan berbasis penelitian – Dr. Sec menjabat sebagai Perwakilan Dokter Spesialis Asosiasi Onkologi Medis Turki.

• Lebih dari 5 tahun pengalaman di bidang onkologi medis
• Menerbitkan berbagai studi tentang hasil pengobatan kanker
• Anggota Asosiasi Onkologi Medis Turki
• Bekerja di Rumah Sakit Bahçelievler Medikalpark

Dr. Rabin mengoordinasikan perawatan kanker di Rumah Sakit Sheba Tel Hashomer dan menjalani pelatihan di MD Anderson Cancer Center yang terkemuka.

• Menyelesaikan residensi di bidang onkologi dan radioterapi
• Fellowship di bidang onkologi ginekologi di MD Anderson
• Pengalaman luas dalam mengobati tumor sistem reproduksi wanita
• Peneliti dalam riset ablasi ultrasonografi terpandu MRI terbaru
• Anggota American Society for Radiation Oncology

Associate Professor Tahsin Ozatli berspesialisasi dalam kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Pengalaman lebih dari 10 tahun di bidang onkologi
• Menempuh pendidikan di Fakultas Kedokteran Universitas Selcuk
• Sebelumnya bekerja di Klinik Onkologi Ankara
• Dipromosikan menjadi Associate Professor pada tahun 2016

Phd Viola Fox memimpin Klinik Hematologi, Onkologi, dan Perawatan Paliatif di BKZ Solingen, yang berspesialisasi dalam pengobatan lanjutan untuk kanker rahim.

• Ahli hematologi, onkologi, dan imunologi bersertifikat dengan pengalaman lebih dari 13 tahun
• Ahli dalam kemoterapi, imunoterapi, dan terapi target
• Spesialis berkualifikasi dalam genetika untuk rencana perawatan yang dipersonalisasi
• Aktif dalam penelitian biologi molekular untuk terapi kanker yang inovatiff
• Anggota masyarakat onkologi Jerman dan Amerika

Profesor Keil mengkhususkan diri dalam teknik pencitraan tingkat lanjut untuk kanker rahim, memanfaatkan pelatihannya yang luas di berbagai rumah sakit terkemuka di Jerman.

• Lulus dengan pujian dari Julius-Maximilians-Universität Würzburg
• Menjadi ahli dalam MRI, CT, dan ultrasonografi untuk intervensi kompleks
• Menjadi Kepala Dokter di Rumah Sakit Akademik Solingen sejak 2022
• Mantan dokter utama di Rumah Sakit Universitas Aachen

Prof. Cemil Bilir berspesialisasi dalam kanker rahim dengan keahlian ganda di bidang onkologi medis dan penelitian kimia anorganik.

• Pengalaman lebih dari 18 tahun di bidang onkologi dengan pelatihan subspesialisasi dari Cleveland Clinic
• Profesor di Universitas Sakarya – pemimpin dalam pendidikan onkologi
• Anggota ASCO, ESMO, dan Perhimpunan Onkologi Medis Turki
• Melakukan penelitian kanker di samping praktik klinis

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Nail Paksoy berspesialisasi dalam pengobatan kanker rahim di Rumah Sakit Medipol Bahçelievler, dengan penelitian ekstensif di bidang onkologi ginekologi.

• Tersertifikasi Dewan ESMO dalam Onkologi Medis
• Mempublikasikan berbagai studi tentang pengobatan kanker endometrium
• Berpartisipasi dalam uji klinis internasional untuk kanker endometrium stadium lanjut
• Menyelesaikan pelatihan fellowship di Institut Onkologi Universitas Istanbul

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Dr. Inta Jaunalksne berspesialisasi dalam viroterapi, sebuah bidang imunologi mutakhir, dengan pengalaman lebih dari 30 tahun.

• Kepala Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulusan Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada perawatan imunologi inovatif

Dr. Alemdar berspesialisasi dalam kanker rahim dengan pelatihan ekstensif di bidang onkologi medis dari Universitas Akdeniz.

• Pengalaman lebih dari 15 tahun di bidang onkologi
• Terlatih di Universitas Akdeniz, lembaga medis terkemuka
• Bekerja di Kompleks Rumah Sakit Medical Park Antalya

Dr. Ozden memiliki lebih dari 20 tahun pengalaman medis, berspesialisasi dalam onkologi dengan fokus pada kanker rahim di Rumah Sakit VM Medical Park Pendik.

• Lulus dari Fakultas Kedokteran Cerrahpaşa yang bergengsi di Universitas Istanbul
• Menyelesaikan subspesialisasi Onkologi Medis di Universitas Kocaeli
• Pengalaman luas di rumah sakit umum maupun swasta
• Mempraktikkan kedokteran dalam sebelum berspesialisasi dalam onkologi

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Hisham Khalifa is a Consultant Surgical Oncologist. He assesses, diagnoses, and operates on gynecological cancers, including ovarian, uterine, cervical, vaginal, and vulval cancers. He performs both minimally invasive (laparoscopic) and open surgery.

Career milestones: Resident and faculty member at the National Cancer Institute, Cairo University (2001–2014). Assistant Professor at AlFaisal University and Assistant Consultant at King Faisal Hospital and Research Center (KFSHRC), Riyadh (2014–2019). Consultant at the NCI, Cairo (2019–present); Director of the Professional Diploma in Gyne-Onco Surgery. Consultant at the Oncology Pediatric Hospital–Alexandria University and Shefa Al Orman Comprehensive Cancer Center, Luxor (2020–present).

Credentials: MBBCh (1999); Master’s in General Surgery (2004); Doctorate in Surgical Oncology (2008); Fellowship of the European Board of Surgery (FEBS, UEMS). Memberships: FACS; SSO; ESSO; ECS; EGSSO.